86 related articles for article (PubMed ID: 26997451)
1. MAP3K3 overexpression is associated with poor survival in ovarian carcinoma.
Jia W; Dong Y; Tao L; Pang L; Ren Y; Liang W; Jiang J; Cheng G; Zhang WJ; Yuan X; Li F
Hum Pathol; 2016 Apr; 50():162-9. PubMed ID: 26997451
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of MAP3K3 promotes tumour growth through activation of the NF-κB signalling pathway in ovarian carcinoma.
Zhang Y; Wang SS; Tao L; Pang LJ; Zou H; Liang WH; Liu Z; Guo SL; Jiang JF; Zhang WJ; Jia W; Li F
Sci Rep; 2019 Jun; 9(1):8401. PubMed ID: 31182739
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
[TBL] [Abstract][Full Text] [Related]
4. DNM3OS Facilitates Ovarian Cancer Progression by Regulating miR-193a-3p/MAP3K3 Axis.
He L; He G
Yonsei Med J; 2021 Jun; 62(6):535-544. PubMed ID: 34027641
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.
Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Chan HY; Cheung AN
Histopathology; 2011 Dec; 59(6):1163-72. PubMed ID: 22175896
[TBL] [Abstract][Full Text] [Related]
6. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
[TBL] [Abstract][Full Text] [Related]
7. REDD1 and p-AKT over-expression may predict poor prognosis in ovarian cancer.
Jia W; Chang B; Sun L; Zhu H; Pang L; Tao L; Zou H; Du J; Dong Y; Qi Y; Jiang J; Liang W; Li F; Zhao X
Int J Clin Exp Pathol; 2014; 7(9):5940-9. PubMed ID: 25337238
[TBL] [Abstract][Full Text] [Related]
8. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
9. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
10. Poly(adenosine diphosphate-ribose) polymerase expression in BRCA-proficient ovarian high-grade serous carcinoma; association with patient survival.
Gan A; Green AR; Nolan CC; Martin S; Deen S
Hum Pathol; 2013 Aug; 44(8):1638-47. PubMed ID: 23574784
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
12. Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.
Denkert C; Schmitt WD; Berger S; Reles A; Pest S; Siegert A; Lichtenegger W; Dietel M; Hauptmann S
Int J Cancer; 2002 Dec; 102(5):507-13. PubMed ID: 12432554
[TBL] [Abstract][Full Text] [Related]
13. Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer.
Vos MC; van der Wurff AA; Bulten J; Kruitwagen R; Feijen H; van Kuppevelt TH; Hendriks T; Massuger LF
Diagn Pathol; 2016 Apr; 11():34. PubMed ID: 27038607
[TBL] [Abstract][Full Text] [Related]
14. Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival.
Luo JH; Xie D; Liu MZ; Chen W; Liu YD; Wu GQ; Kung HF; Zeng YX; Guan XY
Int J Cancer; 2008 Jun; 122(11):2554-61. PubMed ID: 18246597
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin 5/6 expression, prognosis, and association with estrogen receptor α in high-grade serous ovarian carcinoma.
Taube ET; Denkert C; Sehouli J; Unger U; Kunze CA; Budczies J; Dietel M; Braicu E; Darb-Esfahani S
Hum Pathol; 2017 Sep; 67():30-36. PubMed ID: 28414091
[TBL] [Abstract][Full Text] [Related]
16. MiR-194 regulates nasopharyngeal carcinoma progression by modulating MAP3K3 expression.
Yin W; Shi L; Mao Y
FEBS Open Bio; 2019 Jan; 9(1):43-52. PubMed ID: 30652073
[TBL] [Abstract][Full Text] [Related]
17. Aurora-B protein expression is linked to initial response to taxane-based first-line chemotherapy in stage III ovarian carcinoma.
Beussel S; Hasenburg A; Bogatyreva L; Hauschke D; Werner M; Lassmann S
J Clin Pathol; 2012 Jan; 65(1):29-35. PubMed ID: 22011448
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of RFC3 is correlated with ovarian tumor development and poor prognosis.
Shen H; Cai M; Zhao S; Wang H; Li M; Yao S; Jiang N
Tumour Biol; 2014 Oct; 35(10):10259-66. PubMed ID: 25030735
[TBL] [Abstract][Full Text] [Related]
19. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
[TBL] [Abstract][Full Text] [Related]
20. HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival.
Davidson B; Holth A; Hellesylt E; Hadar R; Katz B; Tropé CG; Reich R
Hum Pathol; 2016 Feb; 48():95-101. PubMed ID: 26640230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
